Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pantethine is a naturally occurring compound derived from pantothenic acid (vitamin B5) and consists of two molecules of pantetheine linked by a disulfide bridge. It acts as an intermediate in the endogenous synthesis of coenzyme A—a critical cofactor in lipid and carbohydrate metabolism. Pantethine is primarily used as a dietary supplement for lowering blood cholesterol and triglycerides (hyperlipidemia), with modest efficacy demonstrated in clinical trials. Its mechanism involves increasing concentrations of chemicals that lower blood cholesterol and triglycerides by supporting coenzyme A production in the liver[1][2][3][7]. In Japan and China, it is available as a prescription drug for hyperlipidemia[2]. It should not be confused with its precursor vitamin B5 (pantothenic acid), which has different pharmacological properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pantethine.